Standout Papers

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibit... 2012 2026 2016 2021 480
  1. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma (2012)
    Loredana Santo, Teru Hideshima et al. Blood

Immediate Impact

2 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
2024 Standout
2 intermediate papers

Works of Walter C. Ogier being referenced

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
2012 Standout

Author Peers

Author Last Decade Papers Cites
Walter C. Ogier 457 222 56 111 5 615
Allyn M. Kaufmann 302 47 32 123 7 629
Freddy Schoetens 282 68 115 61 6 677
H. Kitayama 387 54 21 191 14 727
Youling Wu 373 53 271 21 10 577
C. Michelle Dunaway 441 210 146 47 8 652
Joerg Berghausen 448 157 82 14 9 645
Matthew S. Crowe 278 217 21 20 8 659
Tianjian Lu 216 327 11 30 5 628
D. Deprez-De Campeneere 288 217 83 46 9 602
Lisa M. Hollingshead 188 165 52 54 5 573

All Works

Loading papers...

Rankless by CCL
2026